Government shutdown threatens biosimilar approvals, patent litigation – Healio
Government shutdown threatens biosimilar approvals, patent litigation Healio As the ongoing partial government shutdown continues in the United States, the FDA has approximately 5 weeks until drug user fees completely dry up, …